Comprehensive Cancer Screening
Diagnostics
Kuanzia
$300
Hadi $2,500 kulingana na kituo
Muda wa kawaida
2–3 days
Ikiwemo uchunguzi wa kabla ya upasuaji
Hospitali washirika
0
Zimechunguzwa kwa data ya matokeo na vyeti
Muhtasari
Mpango wa kugundua saratani nyingi mapema unaounganisha colonoscopy, mammografia, skaning ya CT ya mapafu ya kipimo kidogo, upimaji wa PSA, alama za uvimbe, na tathmini ya hatari ya kijenetiki ili kukamata saratani katika hatua inayoweza kutibiwa zaidi. Kusafiri nje ya nchi kwa uchunguzi kunampa mgonjwa ufikiaji wa uchunguzi wa hali ya juu wa saratani kwa gharama ndogo sana.
Kesi yako inalinganishwa na kituo kwa msingi wa data ya matokeo ya kitabibu, si matangazo. Tunaratibu kila hatua — kuanzia uchunguzi wa kabla ya upasuaji hadi ufuatiliaji wa baada ya matibabu — pamoja na mratibu maalum wa huduma.
Kinachojumuishwa
Comprehensive Cancer Screening
Imeratibiwa kuanzia
au tutumie ujumbe kwenye WhatsApp
Hakuna ahadi inayohitajika. Data yako kamwe haishirikiwi na wahusika wengine.
Ulinganisho wa gharama duniani — Comprehensive Cancer Screening
Wastani wa gharama zilizoratibiwa katika vituo vyetu washirika. Bei ya mwisho inategemea uzito wa kitabibu na hospitali iliyochaguliwa.
| Nchi | Wastani wa gharama | ikilinganishwa na ya bei nafuu zaidi |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $500 | —chevron_right |
🇹🇷 Turkey Istanbul | $1,000 | +100%chevron_right |
Gharama ni za makadirio na zinapitiwa kila robo mwaka. Omba makadirio ya kibinafsi kwa kesi yako mahususi.
Maswali yanayoulizwa mara kwa mara
The standard package screens for the most prevalent cancers in the international patient population: colorectal cancer (via colonoscopy), breast cancer (via digital mammography), lung cancer (via low-dose CT, recommended for smokers and high-risk patients), prostate cancer (via PSA blood test), ovarian cancer (via CA-125 and pelvic ultrasound), and general tumour markers including CEA and AFP. An optional genetic panel can assess hereditary risk for BRCA-related breast and ovarian cancers, Lynch syndrome for colorectal cancer, and other hereditary conditions. Your coordinating oncologist will recommend the most appropriate sub-panel based on your age, sex, and family history.
Hakuna ada. Hakuna ahadi.
Muongozo wetu ni wa bure kabisa
Tunalipwa na hospitali zetu washirika — kamwe na wagonjwa. Unapata ulinganishaji huru wa kitabibu, uwazi wa gharama, na uratibu kamili bila gharama kwako.
